Observational Study of Effectiveness and Tolerability of Gliclazide MR 60mg in Diabetic Patients Fasting During RAMADAN
CompletedOBSERVATIONAL
Enrollment
1,200
Participants
Timeline
Start Date
March 11, 2019
Primary Completion Date
October 4, 2019
Study Completion Date
October 4, 2019
Conditions
Type 2 Diabetes
Trial Locations (1)
92284
Servier Affaires Medicales, Suresnes
All Listed Sponsors
lead
Servier Affaires Médicales
INDUSTRY
NCT04132934 - Observational Study of Effectiveness and Tolerability of Gliclazide MR 60mg in Diabetic Patients Fasting During RAMADAN | Biotech Hunter | Biotech Hunter